Pharmaco Diagnostics - Clinical Trial Service Testing

Several pharmaceutical companies, such as Merck KGaA and Roche, have incorporated the MGMT test into clinical trials for new brain cancer therapies. With the results of these trials and many others underway, it is hoped that, in the near future, patients with advanced brain cancers will be treated with those therapies that are most likely to result in a longer and higher quality of life. We are currently working in conjunction with other pharmaceutical companies for clinical trials in different cancer areas.